Positive News SentimentPositive NewsNASDAQ:PMD Psychemedics (PMD) Stock Price, News & Analysis $2.32 -0.01 (-0.43%) (As of 10/28/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends About Psychemedics Stock (NASDAQ:PMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Psychemedics alerts:Sign Up Key Stats Today's Range$2.31▼$2.3450-Day Range$2.27▼$2.3452-Week Range$1.63▼$3.93Volume56,284 shsAverage Volume17,365 shsMarket Capitalization$13.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPsychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.Read More… Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Psychemedics Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks16th Percentile Overall ScorePMD MarketRank™: Psychemedics scored higher than 16% of companies evaluated by MarketBeat, and ranked 945th out of 997 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Psychemedics.Read more about Psychemedics' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Psychemedics is -2.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Psychemedics is -2.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPsychemedics has a P/B Ratio of 2.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Psychemedics' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.55% of the float of Psychemedics has been sold short.Short Interest Ratio / Days to CoverPsychemedics has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Psychemedics has recently increased by 11.87%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldPsychemedics does not currently pay a dividend.Dividend GrowthPsychemedics has only been increasing its dividend for 1 years.Read more about Psychemedics' dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.55% of the float of Psychemedics has been sold short.Short Interest Ratio / Days to CoverPsychemedics has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Psychemedics has recently increased by 11.87%, indicating that investor sentiment is decreasing significantly. News and Social Media3.3 / 5News SentimentN/A News SentimentPsychemedics has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Psychemedics this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Psychemedics insiders have not sold or bought any company stock.Percentage Held by Insiders24.00% of the stock of Psychemedics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 32.07% of the stock of Psychemedics is held by institutions.Read more about Psychemedics' insider trading history. Receive PMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Psychemedics and its competitors with MarketBeat's FREE daily newsletter. Email Address PMD Stock News HeadlinesPsychemedics Corporation (PMD)October 15, 2024 | finance.yahoo.comPsychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair TestingSeptember 26, 2024 | globenewswire.comProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.October 29, 2024 | Weiss Ratings (Ad)Psychemedics Corporation Launches New Ketamine Hair Testing ServiceAugust 29, 2024 | finance.yahoo.comPsychemedics Corporation Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 | globenewswire.comPsychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common StockAugust 12, 2024 | finance.yahoo.comPsychemedics Corporation's Board of Directors Approves Plan to Terminate Registration of Its Common StockAugust 12, 2024 | globenewswire.comPsychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair TestingJune 21, 2024 | globenewswire.comSee More Headlines PMD Stock Analysis - Frequently Asked Questions How have PMD shares performed this year? Psychemedics' stock was trading at $2.96 on January 1st, 2024. Since then, PMD stock has decreased by 21.6% and is now trading at $2.32. View the best growth stocks for 2024 here. How were Psychemedics' earnings last quarter? Psychemedics Co. (NASDAQ:PMD) posted its earnings results on Tuesday, August, 13th. The company reported ($0.14) earnings per share for the quarter. The firm had revenue of $4.73 million for the quarter. Psychemedics had a negative trailing twelve-month return on equity of 68.43% and a negative net margin of 21.50%. How do I buy shares of Psychemedics? Shares of PMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Psychemedics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Psychemedics investors own include Pfizer (PFE), NVIDIA (NVDA), DraftKings (DKNG), UnitedHealth Group (UNH), Canopy Growth (CGC), Advanced Micro Devices (AMD) and McDonald's (MCD). Company Calendar Last Earnings8/13/2024Today10/29/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryHealthcare Current SymbolNASDAQ:PMD CUSIPN/A CIK806517 Webwww.psychemedics.com Phone(978) 206-8220Fax978-264-9236Employees140Year Founded1985Profitability EPS (Most Recent Fiscal Year)($0.77) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,150,000.00 Net Margins-21.50% Pretax Margin-16.61% Return on Equity-68.43% Return on Assets-37.48% Debt Debt-to-Equity RatioN/A Current Ratio1.60 Quick Ratio1.60 Sales & Book Value Annual Sales$20.79 million Price / Sales0.65 Cash FlowN/A Price / Cash FlowN/A Book Value$1.15 per share Price / Book2.02Miscellaneous Outstanding Shares5,806,000Free Float5,071,000Market Cap$13.47 million OptionableNot Optionable Beta0.66 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:PMD) was last updated on 10/29/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk Drops Stunning Bombshell?Elon Musk just dropped a BOMBSHELL that could send shockwaves throughout the tech industry… While deliverin...Paradigm Press | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psychemedics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psychemedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.